Analysis of Risk Factors for Death of Covid-19 Patients at Undata Hospital Palu
Abstract
Patients with comorbid are above 45 years on average. Diabetes and heart disease are risk factors for death from COVID-19 because those with diabetes have a 4.384 times greater risk of dying from Covid-19 than patients without diabetes. Patients with heart disease have a 4.319 times greater risk of dying from Covid -19 of the patients without comorbidities. This research aims to determine the risk factors for death of COVID-19 patients at Undata Hospital Palu. This is an analytical survey research with case control study method. The total sample is 62 samples consisting of 31 cases and 31 controls using the statistical test, namely the Odds Ratio. The results show that age is a risk factor with an OR value of 5.975>1, gender is a risk factor with an OR value of 1.304>1 and comorbidities are a risk factor with an OR value of 11.979 > 1. For Undata Hospital, it is expected to further improve the quality of Covid services, especially for patients who have age and comorbid risks so as to speed up the healing process of COVID-19 patients and reduce the death rate due to Covid-19.
References
2. Setiawan AR. Scientific literacy activity sheet for distance learning the topic of coronavirus disease 2019 (COVID-19). Edukatif J Ilmu Pendidik. 2020;2(1):28–37.
3. Jaringan MNKID. Social Services to Minimize Contagious Effects (Corona Virus Spread Cases in Indonesia). J Sos Hum Ter. 2020;2(2):117–25.
4. Fang Y. Fang Y, Zhang H, Xie J, et al. Sensit chest CT COVID-19 Comp to RT-PCR Radiol. 2020;200432.
5. KEMENKES RI. Technical Guidelines for Hospital Services During the Adaptation of New Habits. Jakarta Directorate of Referral Health Services Directorate General of Health Services Ministry of Health RI. 2020;
6. Pademe AC. Analysis of the Relationship between Workload and Work Motivation of Administrative Contract Employees at UPT. Undata Regional General Hospital, Central Sulawesi Province. J Kolaboratif Sains. 2021;4(12):648–53.
7. Ri K. Guidelines for the Prevention and Control of Coronavirus Disease (COVID-19). Kemenkes RI, 0–115. 2020;
8. Satria RMA, Tutupoho RV, Chalidyanto D. Analysis of Death Risk Factors with Covid-19 Comorbid Diseases. J Keperawatan Silampari. 2020;4(1):48–55.
9. Adisasmito W. Health system. 2007;
10. Aditia A. Covid-19: Epidemiology, Virology, Transmission, Clinical Symptoms, Diagnosis, Management, Risk Factors and Prevention. J Penelit Perawat Prof. 2021;3(4):653–60.
Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.